Long-term Health Outcomes of New Persistent Opioid Use After Gastrointestinal Cancer Surgery.
Mujtaba KhalilSelamawit WoldesenbetMuhammad Musaab MunirMuhammad Muntazir Mehdi KhanZayed RashidAbdullah AltafErryk KatayamaYutaka EndoMary DillhoffSusan TsaiTimothy M PawlikPublished in: Annals of surgical oncology (2024)
Approximately 1 in 15 patients experienced NPOU after GI cancer surgery. NPOU was associated with an increased risk of subsequent hospital visits and higher mortality. Targeted interventions for individuals at higher risk for NPOU after surgery should be used to help mitigate the harmful effects of NPOU.
Keyphrases
- papillary thyroid
- minimally invasive
- coronary artery bypass
- end stage renal disease
- squamous cell
- newly diagnosed
- ejection fraction
- healthcare
- chronic kidney disease
- cardiovascular events
- prognostic factors
- emergency department
- peritoneal dialysis
- lymph node metastasis
- cardiovascular disease
- surgical site infection
- type diabetes
- squamous cell carcinoma
- risk factors
- cancer therapy
- coronary artery disease
- patient reported outcomes
- drug delivery
- acute coronary syndrome
- young adults
- percutaneous coronary intervention
- patient reported